文献

J-GLOBAL ID：201702237475339814   整理番号：17A0655923

HER2陰性転移性乳癌患者のファーストライン化学療法としてのnab-パクリタキセルのランダム化第II相試験

Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer

著者 (22件)： Tamura Kenji (Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Inoue Kenichi (Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan) ,  Masuda Norikazu (Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Osaka, Japan) ,  Takao Shintaro (Department of Breast Surgery, Hyogo Cancer Center, Hyogo, Japan) ,  Kashiwaba Masahiro (Department of Surgery, Iwate Medical University, Iwate, Japan) ,  Tokuda Yutaka (Department of Breast and Endocrine Surgery, Tokai University Hospital, Kanagawa, Japan) ,  Iwata Hiroji (Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan) ,  Yamamoto Naohito (Division of Breast Surgery, Chiba Cancer Center, Chiba, Japan) ,  Aogi Kenjiro (Department of Surgery, Shikoku Cancer Center, Ehime, Japan) ,  Saeki Toshiaki (Department of Breast Oncology, Saitama Medical University International Medical Center, Saitama, Japan) ,  Nakayama Takahiro (Department of Breast and Endocrine Surgery, Osaka University Hospital, Osaka, Japan) ,  Sato Nobuaki (Department of Breast Surgery, Niigata Cancer Center, Niigata, Japan) ,  Toyama Tatsuya (Department of Breast Surgery, Nagoya City University Hospital, Aichi, Japan) ,  Ishida Takanori (Department of Surgical Oncology, Graduate School of Medicine, Tohoku University, Miyagi, Japan) ,  Arioka Hitoshi (Department of Medical Oncology, Yokohama Rosai Hospital, Kanagawa, Japan) ,  Saito Mitsue (Department of Breast Oncology, Juntendo University Hospital, Tokyo, Japan) ,  Ohno Shinji (Department of Breast Oncology, National Kyushu Cancer Center, Fukuoka, Japan) ,  Yamauchi Hideko (Department of Breast Surgery, St. Luke’s International Hospital, Tokyo, Japan) ,  Yamada Kimito (Department of Breast Surgery, Tokyo Medical University Hospital, Tokyo, Japan) ,  Watanabe Junichiro (Department of Breast Oncology, Shizuoka Cancer Center, Shizuoka, Japan) ,  Ishiguro Hiroshi (Department of Target Therapy Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Fujiwara Yasuhiro (Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
資料名： Cancer Science (Web)  (Cancer Science (Web))
巻： 108  号： 5  ページ： 987-994  発行年： 2017年 
JST資料番号： U0505A  ISSN： 1349-7006  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 臨床試験においてナノ粒子アルブミン結合パクリタキセル(nab...

シソーラス用語： *抗腫瘍薬 ,...
準シソーラス用語： *HER2陰性乳癌 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0655923&from=J-GLOBAL&jstjournalNo=U0505A") }}

著者キーワード (5件)： albumin-bound paclitaxel ,  docetaxel ,  metastatic breast cancer ,  phase II ,  weekly regimen

分類 (3件)： 腫ようの薬物療法  (GE03032C) ,  抗腫よう薬の臨床への応用  (GW16020L) ,  免疫療法薬・血液製剤の臨床への応用  (GW22020O)

物質索引 (1件)： ドセタキセル

引用文献 (32件)：

• American Cancer Society. Learn about cancer. What are the key statistics about breast cancer? [Cited 01 Nov 2016.] Available from URL: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-key-statistics.
• Cancer Information Service. Projected cancer statistics, 2016. [Cited 18 Aug 2016.] Available from URL: http://ganjoho.jp/en/public/statistics/short_pred.html.
• Ghersi D, Wilcken N, Simes RJ. A systematic review of taxane-containing regimens for metastatic breast cancer. Br J Cancer 2005; 93: 293-301.
• Biganzoli L, Cufer T, Bruning P et al. Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: the European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial. J Clin Oncol 2002; 20: 3114-21.
• Sledge GW, Neuberg D, Bernardo P et al. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol 2003; 21: 588-92.

タイトルに関連する用語 (7件)： HER2 ,  転移性乳癌 ,  患者 ,  ファーストライン化学療法 ,  パクリタキセル ,  ランダム化 ,  第II相試験